CAS: 1246812-13-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Lubiprostone M14 Metabolite REF: 4Z-L-2115CAS: 1246812-13-4 | - - - | A consultar | Mar 07 Ene 25 |
 | (7α,11)-Dihydroxy-5-keto-12,12-difluorotetranorprosta-1,16-dioic Acid REF: TR-D452835CAS: 1246812-13-4 | - - - | 49.320,00 € | Lun 10 Feb 25 |
 | (7α,11)-Dihydroxy-5-keto-12,12-difluorotetranorprosta-1,16-dioic acid REF: 3D-WZB81213CAS: 1246812-13-4 | Min. 95% | - - - | Producto descatalogado |
Ref: 4Z-L-2115
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
(7α,11)-Dihydroxy-5-keto-12,12-difluorotetranorprosta-1,16-dioic Acid
Producto controladoCAS:1246812-13-4
Applications A metabolite of Lubiprostone (L473500).
Fórmula:
C16H24F2O7
Forma y color:
Neat
Peso molecular:
366.354
Ref: TR-D452835
| 25mg | 49.320,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Febrero de 2025
(7α,11)-Dihydroxy-5-keto-12,12-difluorotetranorprosta-1,16-dioic acid
CAS:1246812-13-4
Please enquire for more information about (7Alpha,11)-Dihydroxy-5-keto-12,12-difluorotetranorprosta-1,16-dioic acid including the price, delivery time and more …
Fórmula:
C16H24F2O7
Pureza:
Min. 95%
Peso molecular:
366.35 g/mol
Ref: 3D-WZB81213
| 1mg | Descatalogado | Solicitar información |
